ArticleFrontiers in pharmacology2026

Corticosteroid-responsive portal lymphadenopathy mimicking malignant progression induced by furmonertinib in EGFR-mutated NSCLC: a case report.

Nengyang Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.